Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BCG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,366
Award facts
- Contract value 100% obligated
- $13,365.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dupixent 300 mg/2 mL pen injections valued at $13,365.69. This is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this a specialized pharmaceutical supply supporting military healthcare needs.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen regularly fulfills competitively awarded delivery orders across multiple therapeutic domains, demonstrating its established capability to meet federal pharmaceutical distribution requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F9BCG?
SPE2DR26F9BCG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F9BCG worth?
The government has obligated $13,366 on SPE2DR26F9BCG.
Is contract SPE2DR26F9BCG an order under another contract?
Yes. SPE2DR26F9BCG is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BCG competed?
The extent of competition for SPE2DR26F9BCG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award